Literature DB >> 24916357

Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation.

Safa Baris1, Ilka Schulze, Ahmet Ozen, Elif Karakoç Aydıner, Emel Altuncu, Gulsun Tezcan Karasu, Nilufer Ozturk, Myriam Lorenz, Klaus Schwarz, Thomas Vraetz, Stephan Ehl, Isil B Barlan.   

Abstract

PURPOSE: IPEX (Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked) is a rare X-linked recessive life-threatening disorder characterized by autoimmunity and early death. Pulmonary complication related with IPEX has not been elucidated exactly. Here, we report 4 IPEX patients, 3 of which died from severe pulmonary disease.
METHODS: Clinical data and laboratory findings including autoantibodies, immunoglobulin levels as well as number of T, B and NK cells were evaluated. FOXP3 expression and T reg activity were analyzed. The FOXP3 gene was sequenced and RNA analysis was performed.
RESULTS: Patient I (PI) presented with nephrotic syndrome at 3 years of age and then developed autoimmune hepatitis without eczema, enteropathy or high IgE and died at 9 years of age due to acute respiratory distress syndrome (ARDS). Two cousins of PI had the same hypomorphic splice site mutation leading to a deletion of 27 amino acids, but normal FOXP3 protein expression and normal suppressive capacity of T reg in a proliferation inhibition assay. However, they exhibited typical symptoms such as eczema, diabetes and enteropathy with eosinophilia at early age (PII, PIII) and were transplanted in infancy. One of them had severe respiratory distress right after birth (PIII). Patient IV from another family presented with chronic diarrhea without autoimmune manifestations and died due to ARDS.
CONCLUSION: Lung disease related to IPEX syndrome has not been reported before and this entity could be a critical factor in disease outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24916357     DOI: 10.1007/s10875-014-0059-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Lauri M Burroughs; Troy R Torgerson; Rainer Storb; Paul A Carpenter; David J Rawlings; Jean Sanders; Andrew M Scharenberg; Suzanne Skoda-Smith; Janet Englund; Hans D Ochs; Ann E Woolfrey
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

2.  Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells.

Authors:  Alicia N McMurchy; Jana Gillies; Sarah E Allan; Laura Passerini; Eleonora Gambineri; Maria Grazia Roncarolo; Rosa Bacchetta; Megan K Levings
Journal:  J Allergy Clin Immunol       Date:  2010-10-30       Impact factor: 10.793

3.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.

Authors:  Hiroto Katoh; Zhaohui S Qin; Runhua Liu; Lizhong Wang; Weiquan Li; Xiangzhi Li; Lipeng Wu; Zhanwen Du; Robert Lyons; Chang-Gong Liu; Xiuping Liu; Yali Dou; Pan Zheng; Yang Liu
Journal:  Mol Cell       Date:  2011-12-09       Impact factor: 17.970

5.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

Review 6.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

Review 7.  An update on pulmonary complications of hematopoietic stem cell transplantation.

Authors:  Amy K Chi; Ayman O Soubani; Alexander C White; Kenneth B Miller
Journal:  Chest       Date:  2013-12       Impact factor: 9.410

8.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Int Immunol       Date:  2007-06-22       Impact factor: 4.823

Review 9.  The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  Eva d'Hennezel; Khalid Bin Dhuban; Troy Torgerson; Ciriaco A Piccirillo; Ciriaco Piccirillo
Journal:  J Med Genet       Date:  2012-05       Impact factor: 6.318

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

View more
  13 in total

1.  Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

Authors:  Ayca Kiykim; Ismail Ogulur; Esra Dursun; Louis Marie Charbonnier; Ercan Nain; Sukru Cekic; Dilek Dogruel; Neslihan Edeer Karaca; Mujde Tuba Cogurlu; Ozlem Arman Bilir; Murat Cansever; Hasan Kapakli; Dilek Baser; Nurhan Kasap; Seyhan Kutlug; Derya Ufuk Altintas; Ahmad Al-Shaibi; Nourhen Agrebi; Manolya Kara; Ayla Guven; Ayper Somer; Cigdem Aydogmus; Nuray Aktay Ayaz; Ayse Metin; Metin Aydogan; Aysen Uncuoglu; Turkan Patiroglu; Alisan Yildiran; Sukru Nail Guner; Sevgi Keles; Ismail Reisli; Guzide Aksu; Necil Kutukculer; Sara S Kilic; Mustafa Yilmaz; Elif Karakoc-Aydiner; Bernice Lo; Ahmet Ozen; Talal A Chatila; Safa Baris
Journal:  J Allergy Clin Immunol Pract       Date:  2019-06-22

2.  Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

Authors:  Raymond J Louie; Queenie K-G Tan; Jennifer B Gilner; R Curtis Rogers; Noelle Younge; Stephanie B Wechsler; Marie T McDonald; Barbara Gordon; Christopher A Saski; Julie R Jones; Shelley J Chapman; Roger E Stevenson; John W Sleasman; Michael J Friez
Journal:  Am J Med Genet A       Date:  2017-03-20       Impact factor: 2.802

Review 3.  Regulatory T cells and minimal change nephropathy: in the midst of a complex network.

Authors:  R Bertelli; A Bonanni; A Di Donato; M Cioni; P Ravani; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2015-10-12       Impact factor: 4.330

4.  The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency.

Authors:  Hatice Ezgi Barış; Ayça Kıykım; Ercan Nain; Ahmet Oğuzhan Özen; Elif Karakoç-Aydıner; Safa Barış
Journal:  Turk Pediatri Ars       Date:  2016-12-01

Review 5.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

6.  Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.

Authors:  Oded Shamriz; Bella Shadur; Adeeb NaserEddin; Irina Zaidman; Natalia Simanovsky; Orly Elpeleg; Eitan Kerem; Joel Reiter; Polina Stepensky
Journal:  Eur J Pediatr       Date:  2018-05-18       Impact factor: 3.183

7.  DOCK8 Deficiency Presenting as an IPEX-Like Disorder.

Authors:  Fayhan J Alroqi; Louis-Marie Charbonnier; Sevgi Keles; Fatima Ghandour; Pierre Mouawad; Rami Sabouneh; Reem Mohammed; Abduarahman Almutairi; Janet Chou; Michel J Massaad; Raif S Geha; Zeina Baz; Talal A Chatila
Journal:  J Clin Immunol       Date:  2017-10-23       Impact factor: 8.317

8.  Adenosine A2A Receptor Deletion Blocks the Beneficial Effects of Lactobacillus reuteri in Regulatory T-Deficient Scurfy Mice.

Authors:  Baokun He; Thomas K Hoang; Dat Q Tran; Jon Marc Rhoads; Yuying Liu
Journal:  Front Immunol       Date:  2017-12-06       Impact factor: 7.561

9.  Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors.

Authors:  Baokun He; Thomas K Hoang; Ting Wang; Michael Ferris; Christopher M Taylor; Xiangjun Tian; Meng Luo; Dat Q Tran; Jain Zhou; Nina Tatevian; Fayong Luo; Jose G Molina; Michael R Blackburn; Thomas H Gomez; Stefan Roos; J Marc Rhoads; Yuying Liu
Journal:  J Exp Med       Date:  2016-12-19       Impact factor: 14.307

10.  Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.

Authors:  Eleonora Gambineri; Sara Ciullini Mannurita; David Hagin; Marina Vignoli; Stephanie Anover-Sombke; Stacey DeBoer; Gesmar R S Segundo; Eric J Allenspach; Claudio Favre; Hans D Ochs; Troy R Torgerson
Journal:  Front Immunol       Date:  2018-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.